CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein complexes

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 473-479

  Wolbink, Gert Jan ^a   Brouwer, Mieke C ^a   Buysmann, Saskia ^b   Ten Berge, Ineke J M ^b   Hack, C Erik ^c  

^a CENTRAL LABORATORY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Netherlands Red Cross Blood T ^*

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; OKT 3;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIGEN-ANTIBODY COMPLEX; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; KINETICS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0029927303     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ballou, S. P., and I. Kushner. 1992. C-reactive protein and the acute phase response. Adv. Intern. Med. 37:313.
2. McCarty, M. 1982. Historical perspective on C-reactive protein. Ann. NY Acad. Sci. 389:1.
3. Volanakis, J. E., and K. W. A. Wirtz. 1979. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281:155.
4. Du Clos, T. W. 1989. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143:2553.
5. DiCamelli, R., L. A. Potempa, J. Siegel, L. Suyehira, K. Petras, and H. Gewurz. 1805. Binding reactivity of C-reactive protein for polycations. J. Immunol. 125: 1933.
6. Vigo, C. 1985. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. J. Biol. Chem. 260:3418.
7. Cermak, J., N. S. Key, R. R. Back, J. Balla, H. S. Jacob, and G. M. Vercellotti. 1993. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513.
8. Tilg, H., E. Vannier, G. Vachino, C. A. Dinarello, and J. W. Mier. 1993. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1-beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178:1629.
9. Kaplan, M. H., and J. E. Volanakis. 1974. Interaction of C-reactive protein complexes with the complement system. J. Immunol. 112:2135.
10. Volanakis, J. E. 1982. Complement activation by C-reactive protein complexes. Ann. NY Acad. Sci. 389:235.
11. Nakayama, S., C. Mold, H. Gewurz, and T. W. du Clos. 1982. Opsonic properties of C-reactive protein in vivo. J. Immunol. 128:2435.
12. Volanakis, J. E. 1982. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalant binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J. Immunol. 128:2745.
13. Volanakis, J. E., and A. J. Narkates. 1983. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway. Mol. Immunol. 20:1201.
14. Wolbink, G. J., J. Bollen, J. W. Baars, R. J. M. Ten Berge, A. J. G. Swaak, J. Paardekooper, and C. E. Hack. 1993. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J. Immunol. Methods 163:67.
15. Hack, C. E., J. Paardekooper, R. J. T. Smeenk, J. J. Abbink, A. J. M. Eerenberg, and J. H. Nuijens. 1988. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3: an analysis with monoclonal antibodies. J. Immunol. 141:1602.
16. Volanakis, J. E., W. L. Clements, and R. E. Schrohenloher. 1978. C-reactive protein: purification by affinity chromatography and physicochemical characterization. J. Immunol. Methods 23:285.
17. van Dam, A. P., and C. E. Hack. 1987. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement. Immunology 61:105.
18. Jacobs, R. J., and M. Reichlin. 1983. Generation of low m.w., C3-bearing immunoglobulin in human serum. J. Immunol. 130:2775.
19. Raasveld, M. H. M., F. J. Bemelman, P. T. A. Schellekens, N. J. F. van Diepen, A. van Dongen, E. A. van Royen, C. E. Hack, and I. J. M. ten Berge. 1995. Complement activation following first dose of OKT3 induces pulmonary sequestration of granulocytes an explanation for respiratory side effects. Kidney Int. 43:1140.
20. Campbell, R. D. A., A. W. Dodds, and R. R. Porter. 1980. The binding of human complement component C4 to antibody-antigen aggregates. Biochem. J. 189:67.
21. Wuillemin, W. A., M. Minnema, J. C. M. Meijers, D. Roem, A. J. M. Eerenberg, J. H. Nuijens, H. ten Cate, and C. E. Hack 1995. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for Cl-inhibitor. Blood 85:1517.
22. Nuijens, J. H., C. C. M. Huijbregts, M. Cohen, G. O. Vries, A. de Vries, A. J. M. Eerenberg, J. C. Bakker, and C. E. Hack. 1987. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-c1-inhibitor and kallikrein-C1-inhibitor complexes by specific radioimmunoassays. Thromb. Haemost. 58:778.
23. Hack, C. E., J. Paardekooper, and F. van Milligen. 1990. Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3." J. Immunol. 144:4249.
24. Fries, L. F., T. A. Gaither, C. H. Hammer, and M. Frank. 1984. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J. Exp. Med 160:1640.
25. Law, S. K. A., and A. W. Dodds. 1990. C3, C4 and C5: the thioester site. Biochem. Soc. Trans. 18:1155.
26. Thijs, L. G., C. E. Hack, R. J. M. Strack van Schijndel, J. H. Nuijens, G. J. Wolbink, A. J. M. Eerenberg-Belmer, van der H. Vall, and J. Wagstaff. 1989. Complement activation and high-dose of interleukin-2. Lancet 2:395.
27. Hack, C. E., J. H. Nuijens, R. J. F. Felt-Bersma, W. O. Schreuder, A. J. M. Eerenberg-Belmer, J. Paardekooper, W. Bronsveld, and L. G. Thijs. 1989. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am. J. Med. 86:20.
28. Pruzanski, W., and P. Vadas. 1991. Phospholipase A2: a mediator between proximal and distal effectors of inflammation. Immunol. Today 12:143.
29. Fourcade, O., M. F. Simon, C. Viode, N. Rugani, F. Leballe, A. Ragab, B. Fournie, L. Sarda, and H. Chap. 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophospatidic acid in membrane vesicles shed from activated cells. Cell 80:919.